2021 American Transplant Congress » Kidney Acute Antibody Mediated Rejection

Date & Time:
None. Available on demand

Location: Virtual

Session Type: Poster Abstract

Meeting: 2021 American Transplant Congress

A2 to B Deceased Donor Renal Transplantation Outcome Analysis: Single Center Experience

S. Bindroo, M. Doshi
Clinical Validation and Performance of Donor-Derived Cell-Free DNA in Allograft Rejection

S. Anand¹, A. Pai², J. S. Bromberg³, G. Gupta⁴, I. Moinuddin⁴, T. Alhamad⁵, V. Bowers⁶, S. Ghosh⁷, W. Tian⁷, L. Bu⁸, E. Stites⁹
Combined Impact of Pre-sensitization and Delayed Graft Function on Allograft Rejection in Deceased Donor Kidney Transplantation: A Nationwide Cohort Study

H. Lee¹, Y. Park¹, T. Ban², S. Song³, S. Song⁴, J. Yang⁵, C. Ahn⁵, C. Yang¹, B. Chung¹
Comparing Bortezomib Protocol versus IVIG/Rituximab in the Treatment of Antibody Mediated Rejection (AMR) in Kidney Transplantation

V. M. Lowery¹, A. Centeno¹, T. Harrison¹, P. Cabrera¹, A. Mattiazzi²
De Novo Membranous Nephropathy Associated with Antibody-mediated Rejection in Renal Transplant Recipients

M. V. Sousa¹, L. G. Fernandes², L. L. de Freitas³, R. L. Zollner², M. Mazzali¹
Detection of Rejection in Kidney Transplant Patients Using an Algorithm That Combines Donor Fraction and Absolute Donor-derived Cell-free DNA

S. Bunnapradist¹, E. Ahmed², M. Maninder², Z. P. Demko², P. R. Billings², H. Tabriziani², P. Gauthier³
Donor Derived Cell Free Dna: Teasing Out the Optimal Threshold for Antibody Mediated Rejection

M. Mattu¹, H. Murad¹, M. Merzkani¹, A. Malone¹, R. Delos Santos¹, M. Wang², B. Wang², S. Chang², T. Alhamad¹
Donor Derived Cell-free DNA Kinetics Early After Kidney Transplant in Patients with Delayed Graft Function Who Received Kidneys from Donation After Cardiac Death Donors

R. Gumber, M. Abuzeineh, C. Mejia, D. Brennan, F. Naqvi
Graft Outcomes of Antibody Mediated Rejection without Donor Specific Anti – HLA Antibodies After Kidney Transplantation

H. Ko, S. Min, A. Han, S. Ahn, C. T. Chung, H. Kim, K. Choi, S. Min, H. Kang, J. Ha
Membrane versus Centrifuge‑Based Therapeutic Plasma Exchange to Treat Antibody-Mediated Rejection in Kidney Transplantation

P. Maggiani¹, J. C. Ramirez Valdestino¹, J. H. Cano Cervantes¹, O. D. Díaz Avedaño¹, G. García Castillo¹, M. C. Oseguera Vizcaíno², M. A. Covarrubias², M. Matías Carmona¹, D. F. Ovando Morga¹, G. Ramirez Ramirez¹, V. D. Lebrija Córdoba¹, S. Hernandez Estrada¹
Outcomes of Kidney Transplant Recipients with Antibody-mediated Allograft Rejection: A Retrospective Study

A. Al Jurdi¹, L. Goldfarb¹, M. Lafargue², J. Azzi³, L. V. Riella¹
Plasma Donor-Derived Cell-Free DNA Levels Risk-Stratify Kidney Allograft Injury with Isolated Transplant Glomerulitis

L. Bu¹, S. Anand², A. Pai³, J. S. Bromberg⁴, G. Gupta⁵, I. Moinuddin⁵, T. Alhamad⁶, V. Bowers⁷, S. Ghosh⁸, W. Tian⁸, E. Stites⁹
The Clinical Significance of Preformed Anti-HLA-DQ Donor-specific Antibodies on Allograft Outcomes in Kidney Transplantation

S. Lee¹, C. Yang², B. Chung²
The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation

S. Lee¹, C. Yang², B. Chung²
The Role of Donor-derived Cell-free DNA Testing in Detecting Subclinical Kidney Allograft Rejection

M. Dasari¹, J. Hendele², L. Sibulesky², N. Leca³
Treatment and Outcomes of Kidney Transplant Recipients with C4d Negative Antibody Mediated Rejection

M. Walsh, L. Lineberger, M. Brokhof, N. Kenyon, N. Alvey
Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection After Change in Maintenance Immunosuppression Regimens in the First Year Post Kidney Transplant

M. Walsh, V. Peev, L. Lineberger, M. Brokhof, N. Kenyon, N. Alvey
Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies

S. Kant¹, D. Kumar², I. Moinuddin², T. Alhamad³, M. Haris³, J. Gray⁴, B. Dale⁴, M. Bettinotti¹, D. C. Brennan¹

« View all sessions from the 2021 American Transplant Congress